Citation: I. Creese et J. Tepper, IN-VIVO ANTISENSE KNOCKDOWN OF DOPAMINE-RECEPTOR SUBTYPES - BEHAVIORAL AND ELECTROPHYSIOLOGICAL EFFECTS, Journal of neurochemistry, 70, 1998, pp. 24-24
Citation: Ym. Clarkehall et I. Creese, D-1 D-5 ANTAGONIST BLOCKS AMPHETAMINE-INDUCED CONDITIONED PLACE PREFERENCE IN D1 RECEPTOR KNOCKOUT MICE/, The FASEB journal, 11(9), 1997, pp. 3062-3062
Citation: Fi. Tarazi et al., DIFFERENTIAL REGULATION OF DOPAMINE-RECEPTORS AFTER CHRONIC TYPICAL AND ATYPICAL ANTIPSYCHOTIC DRUG-TREATMENT, Neuroscience, 78(4), 1997, pp. 985-996
Citation: Jm. Tepper et al., FUNCTIONAL ROLES OF DOPAMINE D-2 AND D-3 AUTORECEPTORS ON NIGROSTRIATAL NEURONS ANALYZED BY ANTISENSE KNOCKDOWN IN-VIVO, The Journal of neuroscience, 17(7), 1997, pp. 2519-2530
Citation: Wj. Florijn et al., DOPAMINE-RECEPTOR SUBTYPES - DIFFERENTIAL REGULATION AFTER 8 MONTHS TREATMENT WITH ANTIPSYCHOTIC-DRUGS, The Journal of pharmacology and experimental therapeutics, 280(2), 1997, pp. 561-569
Citation: Zj. Dong et al., GTP REGULATION OF (-)-STEPHOLIDINE BINDING TO R-H OF D-1 DOPAMINE-RECEPTORS IN CALF STRIATUM, Biochemical pharmacology, 54(2), 1997, pp. 227-232
Citation: Zy. Zang et I. Creese, DIFFERENTIAL REGULATION OF EXPRESSION OF RAT HIPPOCAMPAL MUSCARINIC RECEPTOR SUBTYPES FOLLOWING FIMBRIA-FORNIX LESION, Biochemical pharmacology, 53(9), 1997, pp. 1379-1382
Citation: Fi. Tarazi et al., REGULATION OF IONOTROPIC GLUTAMATE RECEPTORS FOLLOWING SUBCHRONIC ANDCHRONIC TREATMENT WITH TYPICAL AND ATYPICAL ANTIPSYCHOTICS, Psychopharmacology, 128(4), 1996, pp. 371-379
Citation: I. Creese et al., DOPAMINE-RECEPTOR BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTISCHIZOPHRENIC DRUGS, The Journal of neuropsychiatry and clinical neurosciences, 8(2), 1996, pp. 223-226
Citation: Fi. Tarazi et al., CHRONIC EFFECTS OF TYPICAL AND ATYPICAL NEUROLEPTICS ON GLUTAMATE-RECEPTOR SUBTYPES, Schizophrenia research, 15(1-2), 1995, pp. 167-168
Citation: Fi. Tarazi et al., HALOPERIDOL, RACLOPRIDE AND CLOZAPINE SHARE A COMMON TARGET - MEDIAL PREFRONTAL CORTEX, Schizophrenia research, 15(1-2), 1995, pp. 168-169
Citation: Fi. Tarazi et al., DOPAMINE D-2-LIKE RECEPTORS ARE ELEVATED AFTER CHRONIC TREATMENT WITHTYPICAL AND ATYPICAL NEUROLEPTICS, Schizophrenia research, 15(1-2), 1995, pp. 168-168
Citation: En. Pothos et al., RESTRICTED EATING WITH WEIGHT-LOSS SELECTIVELY DECREASES EXTRACELLULAR DOPAMINE IN THE NUCLEUS-ACCUMBENS AND ALTERS DOPAMINE RESPONSE TO AMPHETAMINE, MORPHINE, AND FOOD-INTAKE, The Journal of neuroscience, 15(10), 1995, pp. 6640-6650
Citation: Fi. Taraz et al., DIFFERENTIAL REGULATION OF DOPAMINE-RECEPTOR SUBTYPES FOLLOWING CHRONIC TYPICAL AND ATYPICAL NEUROLEPTIC TREATMENT, Journal of neurochemistry, 65, 1995, pp. 12-12
Citation: I. Creese et M. Zhang, ANTISENSE OLIGODEOXYNUCLEOTIDE KNOCKOUT OF CNS DOPAMINE-RECEPTORS, The FASEB journal, 8(4), 1994, pp. 10000106-10000106
Authors:
TARAZI FI
SHIRAKAWA O
TAMMINGA CA
CREESE I
Citation: Fi. Tarazi et al., EFFECTS OF ACUTE NEUROLEPTIC TREATMENT ON GLUCOSE-METABOLISM IN THE RAT-BRAIN, Journal of neurochemistry, 62, 1994, pp. 190000105-190000105
Authors:
POTHOS E
HERNANDEZ L
AUERBACH SB
CREESE I
HOEBEL BG
Citation: E. Pothos et al., CHANGES IN BODY-WEIGHT CAN ALTER THE MESOLIMBIC DOPAMINE SYSTEM AND ITS RESPONSE TO FOOD AND DRUGS, Neuropsychopharmacology, 9(2), 1993, pp. 190000030-190000031
Citation: M. Zhang et I. Creese, ANTISENSE OLIGODEOXYNUCLEOTIDE REDUCES BRAIN DOPAMINE-D2 RECEPTORS - BEHAVIORAL-CORRELATES, Neuroscience letters, 161(2), 1993, pp. 223-226